The toxicology of aflatoxins as a basis for public health decisions

被引:322
作者
Wild, CP [1 ]
Turner, PC [1 ]
机构
[1] Univ Leeds, Sch Med, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England
关键词
D O I
10.1093/mutage/17.6.471
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aflatoxins have been extensively studied with respect to their mechanisms of toxicity. An understanding of metabolism, DNA adduct induction, mutagenicity and carcinogenicity has been paralleled by the development of biomarkers of aflatoxin exposure and biological effects (e.g. mutations) applied to human populations. The improvements in exposure assessment and their application in prospective epidemiological studies and the demonstration of a specific mutation in the TP53 gene in hepatocellular carcinomas from areas of high aflatoxin exposure have contributed significantly to the classification of aflatoxins as human carcinogens. In addition to establishing the carcinogenicity of aflatoxins in humans, understanding molecular mechanisms of action has provided the scientific rationale for prevention strategies, including primary and chemoprevention approaches. Overall, integrated, multidisciplinary research on aflatoxins has provided the platform on which to base decisions regarding acceptable exposures and priorities for interventions to reduce human risk in a public health context.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 170 条
[31]   MECHANISM OF AFLATOXIN CARCINOGENESIS [J].
EATON, DL ;
GALLAGHER, EP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :135-172
[32]   Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer [J].
Egner, PA ;
Wang, JB ;
Zhu, YR ;
Zhang, BC ;
Wu, Y ;
Zhang, QN ;
Qian, GS ;
Kuang, SY ;
Gange, SJ ;
Jacobson, LP ;
Helzlsouer, KJ ;
Bailey, GS ;
Groopman, JD ;
Kensler, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14601-14606
[33]  
FORRESTER K, 1995, ONCOGENE, V10, P2103
[34]   BASE SUBSTITUTION MUTATIONS INDUCED BY METABOLICALLY ACTIVATED AFLATOXIN-B1 [J].
FOSTER, PL ;
EISENSTADT, E ;
MILLER, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09) :2695-2698
[35]  
FUJIMOTO Y, 1994, CANCER RES, V54, P281
[36]   MESOSCOPIC LAYERED STRUCTURE IN CONDUCTING POLYMER THIN-FILM FABRICATED BY POTENTIAL-PROGRAMMED ELECTROPOLYMERIZATION [J].
FUJITSUKA, M ;
NAKAHARA, R ;
IYODA, T ;
SHIMIDZU, T ;
TOMITA, S ;
HATANO, Y ;
SOEDA, F ;
ISHITANI, A ;
TSUCHIYA, H ;
OHTANI, A .
SYNTHETIC METALS, 1992, 53 (01) :1-10
[37]   The kinetics of aflatoxin B-1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4 [J].
Gallagher, EP ;
Kunze, KL ;
Stapleton, PL ;
Eaton, DL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 141 (02) :595-606
[38]  
GemechuHatewu M, 1997, INT J CANCER, V73, P587, DOI 10.1002/(SICI)1097-0215(19971114)73:4<587::AID-IJC21>3.0.CO
[39]  
2-5
[40]   INTERCALATION OF AFLATOXIN-B1 IN 2 OLIGODEOXYNUCLEOTIDE ADDUCTS - COMPARATIVE H-1-NMR ANALYSIS OF D(ATCAFBGAT).D(ATCGAT) AND D(ATAFBGCAT)2 [J].
GOPALAKRISHNAN, S ;
HARRIS, TM ;
STONE, MP .
BIOCHEMISTRY, 1990, 29 (46) :10438-10448